The Maharashtra Public Service Commission (MPSC) has called off the recruitment process for the Drug Inspector, Group B position in the Food and Drug Administration department. This decision follows a preliminary investigation into allegations of malpractice during the screening exam held on March 22, 2026.
The commission acted after receiving complaints from candidates and public representatives between July 22 and July 26, claiming that some exam questions were leaked ahead of the test. According to the allegations, the question paper or parts of it were obtained as early as March 20 and circulated through social media and electronic platforms.
How the Paper Leak Came to Light
Following the complaints, MPSC filed a formal report with the Mumbai Police on July 27, requesting an inquiry into the matter. The Deputy Commissioner of Police from the Crime Branch conducted a preliminary investigation and submitted their findings to the commission. The report indicated that at least one candidate had received the question set in advance and gained an unfair advantage. However, the commission did not confirm that the entire question paper was leaked or that multiple candidates benefited from the breach.
In response, MPSC emphasized its commitment to maintaining the confidentiality, integrity, and fairness of its examinations. To protect the credibility of the recruitment process and uphold candidates' trust, the commission decided to cancel the current recruitment cycle.
Key Facts About the Recruitment and Exam
- The recruitment notification was initially released on July 29, 2025.
- The offline screening exam took place on March 22, 2026, across six divisional headquarters in Maharashtra.
- Results were announced on June 12, with 506 candidates shortlisted for interviews.
- Between July 1 and July 22, 488 candidates attended the interviews.
- A provisional merit list was published, featuring 485 selected candidates and three deemed ineligible.
- MPSC will conduct a re-examination for the Drug Inspector posts, and candidates who applied earlier will not need to reapply or pay additional fees.
What This Means for Candidates and the Recruitment Process
The cancellation of the recruitment exam disrupts the hiring timeline for the Drug Inspector positions, potentially delaying appointments in the Food and Drug Administration department. Candidates who had prepared and appeared for the exam must now gear up for a fresh test, though they will not face any extra financial burden or application hurdles.
This incident highlights ongoing challenges in securing examination processes against leaks and malpractice, especially in high-stakes government recruitment. MPSC’s swift action to cancel the exam and order a re-test aims to reinforce transparency and fairness, reassuring candidates and the public that merit remains the cornerstone of selection.
While the exact date for the re-examination has yet to be announced, candidates are advised to stay updated through official MPSC communications. The commission’s approach reflects a broader effort to strengthen examination security and restore confidence in public service recruitment.
Frequently Asked Questions
Q: Why was the Drug Inspector exam cancelled?
A: The exam was cancelled after a preliminary inquiry found evidence that at least one candidate received the question paper before the test, compromising the exam’s integrity.
Q: Will candidates have to pay again or reapply for the re-exam?
A: No, candidates who applied for the original recruitment will not need to submit a new application or pay any additional fees for the re-examination.
Q: When will the re-examination take place?
A: The commission has not yet announced the re-exam date but will do so soon. Candidates should monitor official MPSC announcements for updates.
